Loxo Oncology, Inc
LOXO
LOXO was delisted on the 14th of February, 2019.
158 hedge funds and large institutions have $3.61B invested in Loxo Oncology, Inc in 2018 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 48 increasing their positions, 55 reducing their positions, and 15 closing their positions.
140% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 15
32% more capital invested
Capital invested by funds: $2.74B → $3.61B (+$875M)
12% more funds holding
Funds holding: 141 → 158 (+17)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
13% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 55
52% less call options, than puts
Call options by funds: $16.8M | Put options by funds: $34.9M
316.8% less ownership
Funds ownership: 421.13% → 104.33% (-317%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
+$42.5M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$39.8M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$28.6M |
| 4 |
TCM
TimesSquare Capital Management
New York
|
+$23.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$9.91B |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$84.4M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$26.3M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$18M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$18M |
LOXO Hedge Fund Activity: Q1 2018 in Review
158 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q1 2018, worth a combined $3.61B — up 32% from $2.74B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new LOXO positions and 15 closed out — a net gain of 21 holders — while 48 added to existing stakes and 55 trimmed.
The largest buyer was Boxer Capital, opening a new position worth an estimated $42.5M. The largest seller was OrbiMed, cutting an estimated $9.91B.
- 158 institutional investors held Loxo Oncology, Inc (LOXO) as of Q1 2018, up from 141 in Q4 2017.
- Funds reported $3.61B of Loxo Oncology, Inc stock for Q1 2018, up 32% quarter-over-quarter.
- 36 funds opened new Loxo Oncology, Inc positions in Q1 2018 and 15 closed out, a net change of +21 holders.
- The largest Loxo Oncology, Inc buyer in Q1 2018 was Boxer Capital, an estimated $42.5M added.
- The largest Loxo Oncology, Inc seller in Q1 2018 was OrbiMed, an estimated $9.91B sold.
Based on aggregated 13F filings for Q1 2018.